According to the latest trade data released by the General Administration of Customs of the People's Republic of China, 2FIRSTS has compiled the e-cigarette export data from China to Ireland in September 2023, as follows:
Exports amounted to approximately $6.88 million, representing a sequential growth of 75.29% and a year-on-year increase of 13.30%.
The export volume reached approximately 193 tons, showing a month-on-month increase of 88.20% and a year-on-year increase of 70.86%.
The export unit price declined by 6.86% compared to the previous period and dropped by 33.69% year-on-year, reaching $35.58 per kilogram. The average price of "e-cigarettes and similar personal electronic vaporizers" stood at $7.95 per unit.
Among them, "e-cigarettes and similar personal electronic vaporizers" account for 4.82% of the export category, while "products that do not contain tobacco or reconstituted tobacco but contain nicotine and are not consumed by combustion" account for 95.18%.
According to data predicted by Statista, the revenue of the e-cigarette market in Ireland is projected to reach $118 million by 2023. It is estimated to experience a compound annual growth rate of 3.61% from 2023 to 2028. On a per capita basis, the average e-cigarette consumption in Ireland is expected to be $26.9 in 2023. The popularity of e-cigarettes in Ireland is increasing year by year, with a growing number of consumers adopting their usage.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
